[Skip to Navigation]
Citations 0
July 2006

Open-Label Extension Studies and Misinformation—Reply

Arch Neurol. 2006;63(7):1036-1037. doi:10.1001/archneur.63.7.1036-b

In reply

We thank Dr Schneider for his comments on our report.1 We share his enthusiasm for “well-conducted and methodologically sound randomized controlled trials.”2 However, we do not agree that “as physicians, we should be comfortable prescribing medication for longer periods of time than the length of the randomized trials” based on the evidence from the shorter-term randomized trials and “patients' preferences.” We believe that this prescribing comfort should be informed, to the extent possible, by the best available evidence.

Add or change institution